West Pharmaceutical Services Inc. (WST) Financial Statements (2025 and earlier)

Company Profile

Business Address 530 HERMAN O. WEST DRIVE
EXTON, PA 19341
State of Incorp. PA
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)
Annual | Quarterly

6/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments485854894763616439
Cash and cash equivalent485854894763616439
Receivables553512507489385319
Inventory, net of allowances, customer advances and progress billings377435415378321236
Inventory377435415378321236
Other current assets1241361031125265
Total current assets:1,5381,9361,9201,7421,3741,059
Noncurrent Assets
Operating lease, right-of-use asset10599104696870
Property, plant and equipment1,5821,4131,1581,058943839
Long-term investments and receivables202210205208215193
Long-term investments202210205208215193
Intangible assets, net (including goodwill)117124126133142138
Goodwill106109107110111108
Intangible assets, net (excluding goodwill)111518233130
Regulated entity, other noncurrent assets    1 1
Asset, held-in-trust      11
Deferred costs    16  
Deferred income tax assets2626664916 
Other noncurrent assets742138392325
Other undisclosed noncurrent assets   01136
Total noncurrent assets:2,1051,8931,6971,5721,4201,283
TOTAL ASSETS:3,6433,8303,6173,3142,7942,341
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities271259242261241193
Interest and dividends payable✕✕✕✕  15
Taxes payable✕✕✕✕262613
Employee-related liabilities✕✕✕✕222
Accounts payable239242215232213157
Accrued liabilities321727  6
Deferred revenue      28
Debt1134244210
Other liabilities18815518216314491
Other undisclosed current liabilities911249312611620
Total current liabilities:550672519594503342
Noncurrent Liabilities
Long-term debt and lease obligation20373207272313317
Long-term debt, excluding current maturities20373207209253255
Liabilities, other than long-term debt208204206113123107
Deferred compensation liability, classified151919292313
Deferred income tax liabilities211314510 
Liability, pension and other postretirement and postemployment benefits283028415853
Other liabilities625952383241
Operating lease, liability828593636062
Other undisclosed noncurrent liabilities      3
Total noncurrent liabilities:411277413384436427
Total liabilities:961949932978939768
Equity
Equity, attributable to parent2,6822,8812,6852,3351,8551,573
Common stock191919191919
Treasury stock, value(1,057)(638)(371)(230)(168)(118)
Additional paid in capital 22120232249267273
Accumulated other comprehensive loss(258)(144)(183)(160)(111)(150)
Retained earnings3,9573,5232,9882,4571,8471,549
Total equity:2,6822,8812,6852,3351,8551,573
TOTAL LIABILITIES AND EQUITY:3,6433,8303,6173,3142,7942,341

Income Statement (P&L) ($ in millions)
Annual | Quarterly

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues2,8932,9502,8872,8322,1471,840
Cost of revenue
(Cost of Product and Service Sold)		(1,895)(1,821)(1,751)(1,656)(1,379)(1,234)
Gross profit:9991,1291,1361,176768606
Operating expenses(416)(440)(399)(418)(354)(317)
Other operating income (expense), net(1) 1(1)(1)5
Other undisclosed operating income (loss)(12)(13)(4)(5)(7)3
Operating income:570676734752407297
Nonoperating income (expense)1922(54)(3)(6)4
Investment income, nonoperating20223(3)14
Gain (loss), foreign currency transaction, before tax (9)412 
Other nonoperating income (expense)(1)3(51)41(0)
Interest and debt expense(3)(9)(8)(8)(8)(9)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 9888 
Income from continuing operations before equity method investments, income taxes:586698680749401292
Income from equity method investments15182120179
Other undisclosed loss from continuing operations before income taxes(15)     
Income from continuing operations before income taxes:586716701769419301
Income tax expense(108)(122)(115)(107)(73)(59)
Income from continuing operations:478593586662346242
Income before gain (loss) on sale of properties:✕✕✕✕662346242
Net income:478593586662346242
Other undisclosed net income attributable to parent15     
Net income available to common stockholders, diluted:493593586662346242

Comprehensive Income ($ in millions)
Annual | Quarterly

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income:478593586662346242
Other comprehensive income (loss) (0)(0)(23)(49)395
Other undisclosed comprehensive loss      
Comprehensive income:478593563613385246
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(100)39    
Comprehensive income, net of tax, attributable to parent:378633563613385246

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: